Searched for
QDENGA
India moves closer to dengue vaccine as final trials underwayAn Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentTakeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurit...
- In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
- Dengue virus fever in USA: Over 9.7 million cases reported. Check symptoms, treatmentDengue fever is reported in the US as CDC has provided details about the Symptoms and treatment.
- Japan's Takeda in regulatory talks to launch dengue vaccine in IndiaThe Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...
- Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccineJapanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...
Load More